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p21 WAFliCIPl is a nucleoprotein that was initially 
characterized by its ability to be regulated transcrip-
tionally by p53 and by its ability to mediate growth 
arrest by binding to cyclin-dependent kinases . Al-
though p21wAFtiCIPt is thought to mediate the effects 
of p53 in causing growth arrest, p21WAFt/CIPt is also 
regulated in a p53-independent manner, e.g., during 
terminal differentiation of some cell lines. Growth 
factors including epidermal growth factor also in-
duce p21WAFt/CJPt through p53-independent path-
ways. Because the epidermal growth factor signaling 
pathway is abnormal in psoriatic epidermis, we stud-
ied p21 WAFl/CrPt expression, using in situ hybridiza-
tion and imm.unohistochemistry, in psoriasis. Both 
p21WAFtiCIPl mRNA and protein were significantly 
elevated in untreated psoriatic plaques compared 
T he p53 tumor suppressor gene pla ys a major ro le in contro l of the cell cycle afte· r DNA damage, with loss of fun ction occurring frequently in hum an malig-nan cy, including non-melanoma skin cancer ([1 ,2) and reviewed in [3]) . Up-regulation of the p53 
protei n occurs in response to a variety of DNA-damaging agents, 
includin g gamma [4,5] and ultraviolet (UV) radiation [5- 9] and 
chemotherapeutic drugs [5, 1 0); this resu lts in G 1 arrest or apoptosis 
[1,4,11 ,12). T he possible physio logic relevance of these observa-
tions is em phasized by the induction of p53 protein in hum an skin 
i11 IJiiJo after UV irradiation [7 ,8], with even subcrythcm al doses of 
UV radiation resulting in p53 induction [9]. Altho ugh p53 protein 
inductio n may occur as a direct e!rect of D NA damage, a m echa-
nism of induction reported in earlier stu d ies, other cellular signal-
transd uction pathways may also be in volved in regulatin g p53 
expression, includin g those in volvin g protei n kinase C [13 , 14]. 
R ecently, Anton iades cl n/ [1 5] have shown that p53 mRNA and 
protein arc increased durin g the later stages of tissue repa ir after 
experimental skin wounding, and H ealy el nl [9] have reported 
induction of p53 mRNA and protein in hum an ski.n in 11ivo afte r 
topical app]jcation of skin irritants such as sod ium dodecylsulfate 
(SDS). Spandau [1 6] has aJso reported changes "in p53 prote in 
confo rmati o n within different layers of the epidermis, w hich sug-
gests a ro le for p53 in the control of epidermal di!rerentiation . 
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with uninvolved psoriatic skin (p < 0.0001), with the 
ul • f 21WAF1/CIP1 b • d • 1 up-reg atlon o p emg pre omtnant y 
suprabasal. This increase was accompanied by a small 
increase in p53 protein expression of uncertain sig-
nificance. Furthermore, p21WAFt/CIPt expression was 
induced in skin after sellotape stripping and by the 
application of agents, such as dithranol, that are 
capable of inducing hyperproliferation. The pattern 
of p21 w AFt/ClPt expression observed is consistent with 
a role in induction and maintenance of differentia-
tion. Our experiments, however, cannot determine 
whether the abnormalities of p21 wAFt JcrPt epidermal 
expression in psoriasis and after insult are indepen-
dent of changes in p53 expression . K ey words: dijfeven-
tiatio11 /proliferatiouJp53 /ditiJ ranol. J Invest Demwtol 105: 
274-279, 1995 
T he efrcc ts of p53 in causing growth arrest arc thought to be 
m ediated in part by transcriptional induction of the p21 WAF t/CIPI 
gene, which inhibits the action of G 1 cyclin-dependent kinases 
[17-20] . T he p21 wAr-1/CIP t gene encodes a 21-kD nucleopro tein, 
p21. WAFIICI PI [1.7-19] , which in norm al human cells exis ts in 
quaternary complexes w ith pro]jfcrating-cell nucl ear a11tigen, a 
cycl in , and a cycl in-dependent kinase [21- 23]. ln addition to 
inhjbiti11g the activity of cyclin / cyclin-dependent kinase com-
plexes, p21 WAFIICII' I suppresses proliferating-cell nuclear antigen-
dependent DNA replication and blocks tl1e activation of DNA 
polymerases delta and epsilo n by proli ferating-ce ll nuclear antigen 
[20,24,25] . EI-Deiry et nl [1 9] have also shown that p21 WAFI!CtPI 
mR.NA and protein are indu ced in M3-J3D T - ceU lymphoma cells 
and in BAF3 murine hem atopoie tic cells in association w ith p53-
m ediatcd apoptos is. 
.Recent experiments have provided evidence for the existence of 
two separate pathways of p21 WAF I /CII'I inductio n , o ne de pe ndent 
o n p53 and the other independent of p53 [26]. Work o n cellular 
diffe rentiation has implicated p21 WAPIICIPI in thjs process 11 i n a 
p53-independc nt m echan ism [27,28]. In add ition , and of further 
releva nce to the work reported here, stimulatio n by growth factors 
such as ep iderm al growth factor (EGF) resu lts in a p53-independent 
indu ction of p21 WAF t/CIP I in some system s [26] . An increase in the 
EGF receptor-binding capacity has been dem o nstrated in the upper 
laye rs of psoriatic epidermis [29), and transformi11g growth £ac-
tor-a, an important mitogen in skin that exerts its effects through 
the EGF receptor [30,31] , is al so ele vated in psoriatic e pide rmis 
[32-34] . Because of tlus and the in creasing evidence implicating 
p21 WA I' I/CIPI in the control of cell di!rercntiation [27,28], we 
investigated the i11 11 i11o expression of p21 WAPt /CIPI in psoriasis, a 
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Figure 1. Increa sed expression ofp21wAPIICrPI mRNA and protein in lesiona l psoriatic epidermis as compared w ith non.lesional psoriasis. 
[ 11 s itu hybridization ;md immuno histochemistry were carried ou t as described i11 Mnterinls nud !vletltods. (a) p21 WAI' I/CIPI mR.NA in lcs iona.l psoriasis; (b) 
p2lWAI' I/CIP I protein in lesion al pso riasis; (c) p21 WAI' I/C II'I mR.NA in nonlesional psoriasis; (d) p21 WAF I/C II ' ' protein innonlesional psoriasis. Representative 
; san1ples arc shown . T he dcnnoepidcrn1al junction is rnarked (dotted lines) . Note that the inc reased expression of p2 1 WAF I /CIPI n1ltNA and protein in lcsional 
psoriasis is in the supn1basal layer. Bm>·, 10 /Llll . 
disease cha racterized by abnormal diffe rentiati on and prolife1·ation. 
To determin e whether p21 WAFl / C IPI up-regula tion in psoriasis is 
associated w ith changes in p53, w e also studied the expression of 
p53 mRNA and protein in this condi tion . Furthermore, to examine 
whether p21 WAFI /CIPJ up-regulation is specific for psoriatic epi-
dermis, we inves ti gated whether p21 WAF I / C II'"I induction occurs 
after se!Jotape stripping or appLication of irritan ts such as dithrano l 
an d SDS, all of which induce prolife ration [35- 40]. 
M ATERJALS AND METHODS 
Psoriasis Samples of skin were obtai ned. following in fo rmed conse11 t, 
from 13 ad ult patients with chronic plaque psoriasis. Patients were excluded 
if they had rece ived topical the rapy before biopsy, apart from em o llients fo r 
2 weeks or phototherapy o r systemic agents for 6 m onths. Skin biopsy 
specimens (6 mm in diameter) were taken under loca l anesthesia fi·om 
p soriatic plaques on the lower back and from unin vo lved skin o n the lower 
back at least 5 em fro m the edge of the nea rest ph1que. T he specimens were 
fixed in parafonnaldehyde for 3 h , and embedded in paraffin. Samples fi·om 
the san1 c patien t \vcrc en1 bcddcd in o ne b lock to rninin1i zc variation during 
immunohistochemistry and iu si/ 11 h ybridiza tion. 
Irritants Twen ty-microliter aliquots of di thra no l (1 J.Lg/ J.Ll) in chloroform 
(n = 1 0), SDS (51Yu) in p ropylene g lycol (n = 6), pro pylene glycol alone 
(n = 8), and chlo roform (n = 4) were app li ed topically to the lower back 
of 10 adu lt vo lun teers for 8 o r 48 h , as desc ribed previously f9]. Skin biopsy 
specimens (4 mm in d iameter) were take n fi:o m irri tant-treated ;md no rmal 
skin at these times , fixed in paraform:lidehydc, and embedded in paraffin as 
above. 
Tape Stripping Sellotape stripping of the skin was ca rri ed o ut on a 
1-2- cm area on the lower back of two ad ul t voluntee rs [3 9]. Individual 
pieces of se llotape were applied to and pee led from one area of skin in n 
sequen tial n1anner until the skin g li stened. Biopsy spccinwns \.vcrc taken 
from the stripped skin at 4 and 24 h after stripping in one case ;111d at 24 h 
after stripping in tbe other case. as "vcll as fron1 no nnaJ skin in both cases. 
ln1munohistoch emistry Immuno histoch emistry was performed using a 
m o use m onoclonal antibody (EA 10) to p2 1 WAF I/CIPI (gift fi-om w. 
El-Dciry and B. Vogelstein, J o hns Hopkins O ncology Center). This anti-
body detects a 21-kD band o n Western ana lysis of a va riety of cell lines and 
an increase in immunosta ining after DNA da mage o f ce ll cul tures; after UV 
irradiati on of human skin, it sh ows an identica l patte rn of expression to 
p2·1 \V r\1; ! /C IPI tnR..N A as shown by i11 si111 hybt~i di zatio n. * Using prior 
antigen re trieval by microwaving [41], 4-J.Lm sections were incubated with 
primary antibody at a dilutio n o f 1 :500 for 45 min at room temperature. 
Subsequent detection of the primary antibody was carried out· using 
diaminobenz idine, as described previo usly [9]. T he degree of immunore-
activity was g raded by an o bserver in a blinded fas hion using an ordina l sca le 
of 0 to 4, in whi ch 0 represen ts no stain i11g, 1 is m ild sta ining, 2 is m oderate 
sta ining, 3 is m oderate/strong staining, and 4 is stro ng staining. T he 
distribution of positive ly stained cells, i.e., whethe r high suprabasa l, low 
suprabasa l, basal, pan-epidermal, o r upper dermal. was also recorded. 
lmmunostaining w as ;1lso done after mico·owaving using D07 (Novocastra. 
UK) (a rnousc n to nodonal antibody agai nst rccon1binan t hun1an p53 
protein) and grad ed in a similar manner. Samples of irri tant-treated and 
nonna l skin ' vc.re a lso inunun ost;. incd \\rit h M1131 (In1n1unotech. France). a 
mouse m onoclonal anti bo dy agai nst recombinan t .Ki67 antigen using mi-
crowa ve antigen retri eva l [41 J: the number of positive epidermal nuclei was 
expressed pe r ·1 00 b"sa l ce lls. 
* EI-.Deiry WS . Tokino T. \ Xia ldman T. O liner JD, Velculescu VE, 
13urell M , H ill DE. Healy F, R ees JL, 1-l ami.lr.on SR, Kinzler KW. 
Vogelstein .13: Topologica l control of p2 1 WA I' o/CIP I expression in n orn1a l 
and neoplastic tissues. Cr11rrer R t•s (in press). 
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Figure 2. p21WAFIICIPl mRNA and protein and p53 protein are up-regulated in lesional as compared with nonlesional psoriasis. Iu situ 
hybriclization and immunohistochemistry were performed as described in Materials aud Methods. The intensity of iu situ hybridization and immunohisto-
chemical staining in lesional and nonlesional psoriatic epidermis (graded on a 0- 4 scale) is shown for each of 13 subjects (numbered 1 to 13) with psoriasis. 
a) p53 mRNA; b) p53 protein; c) p21 WAF I/CIPl mRNA; d) p21 WAFI/CU'I protein. C losed bars, lesional psoriasis; sltaded bars, nonlesional psoriasis. 
Probe Preparation Full-length antisense and sense digoxigenin-labeled 
cRNA transcript.' were generated from the 2120-basc pair (bp) p21wAFI/CIPI 
eDNA clone pZL-WAFl (20] (gift from W . El-Deiry and B. Vogebtein,Johns 
Hopkins O ncology Center) using a Digoxigenin RNA labeling kit (Boehringer 
Mannheim), according to the manufacturer's instructions .. Transcripts were 
subsequently hydrolyzed to an average length ofless than 1000 bp (42] before 
recovery by etl1anol precipitation. 
In Situ Hybridization Four-micrometer paraffin sections were subjected 
to iu situ hybridization, as described previously (9,43]. with tl1e fo llowing 
modifications. Sections were hybridized in the presence of 4 X standard 
saline citrate and 50% deionized formamide at 50°C and washed to a fi nal 
stringency of 0.1 X standard saline citrate in 50% formamide at 45°C. The 
resu lts of iu situ hybridization were recorded as described for those of 
i•nn1unohistoch cn1istry. 
Statistics Comparisons between medians were performed with the 
Mann-Whitney test using Minitab for Windows software . 
RESULTS 
Expression of p21~AF1tctPt Protein and mRNA Is Elevated 
in Human Psoriatic Epidermis Normally, p2 l WAF I/CtPt pro-
tein and mRNA expression is low in e pidermal keratinocytes in 
11i t1o . Investigations o n involved and uninvolved skin fi·om patients 
with chronic plaque psoriasis showed that the intensity of nuclear 
immunopositivity, using an anti-p21 WAFt/CtPt protein monoclonal 
antibo dy, was greater in all 13 cases of involved p soriatic epidermis 
than in uninvolved epidermis taken from the sam e patients (Figs 
1,2) (medians 2.5 and 0.5, respectively; p < 0 .0001) . p21 WAF I/ CtPt 
protein expression was highest suprab asally, with little or no 
detectable expression in the basal layer. Similarly, p21 WAFt/CtP t 
mRN A was elevated in the cells of the suprabasal layers of lesional 
psoriatic e pidermis when compared with n onlesional skin in 12 of 
13 cases (Figs 1,2) (medians 2.5 and 1.0, respectively; p < 0 .0001 ). 
Expression ofp53 Protein (But Not p53 mRNA) Is Margin-
ally Elevated in Human Psoriatic Epidermis p53 protein, as 
assessed with the m o noclon al antibody D07, was detected in tl1e 
basal and lower suprabasal layers of involved and uninvolved 
psoriatic epidermis, w ith the involved epidermis showin g a slightly 
higher de~:,>Tee of inmmnopositivity in 10 of 13 subjects (Fig 2). 
Statistical analysis of the median intensities of p53 protein immu-
nostaining for the two groups showed this small difference to be of 
borderline significance (lesional median 1.50, nonlesional median 
> 
VOL. 105. NO. 2 AUGUST 1995 
Table I. Induction of p21 ""AFttCIPt mRNA and Protein" 
in Human Skin In Vivo Mter Application of Irritants 
Comparison Median Values p Value 
mRNA 
Dithranol versus normal 2. 13 versus 0.63 0.006 
Dithranol versus chloroform 2.13 versus 1.13 0.048 
SDS versus nom1al 2.50 versus 0.63 0.017 
SDS versus PG 2.50 versus 1.00 0.048 
Chlorofonn versus normal 1.'13 versus 0.63 0.193 
PG versus normal 2.50 versus 0.63 0.219 
Protein 
Dithranol versus normal 2.63 versus 1.50 0.006 
Dithranol versus chloroform 2.63 versus 1.63 0.007 
SDS versus normal 3.00 versus 1.50 0.018 
SDS versus PG 3.00 ve rsus 2.00 0.007 
Chloroform versus normal 2.63 versus 1.50 0.794 
PG versus normal 2.00 versus 1.50 0.197 
u The medi an intcnslry of in situ hybridization and immunohistochemical staining 
(graded on a 0-4 scale) for p21 WAf- J/C JI'J in the cpidcnnis of skin treated with the 
above substances is shown. Statistical analysis was by the Mann- Whitney test usin g 
Mini tab for Windows software. PG. propylene glycol. Application of topical irritants 
and corresponding bases was fOr 48 h . :-~ s described previously l9]. 
1.25; p = 0.046). fn contrast, p53 mRNA was not elevated in 
lesiona l epidemus (p = 0.92). 
p21""AFIICIPt mRNA and Protein Expression Is Increased in 
p21"11" ' 11C 11 '' EXP~SSION IN PSORJASIS 277 
SDS caused a significant e levation of epidemul p21 WAFt /CtPt 
mRNA and protein at 48 has compared with either base alone (i.e. , 
chloroform and propylene glycol) and compared with normal 
untreated skin (Table I). The elevation of p21 WAFt / '"' was 
evident throughout the epidermis, with signal in both the supra-
basal and basal layers, although the intensity of signal was higher in 
the lower suprabasal layers. Assessment ofKi67 antigen expression 
demonstrated an increase in proEferation after the application of 
irritants; dithranol and SDS caused a fivefold and ninefold increase 
in proEferation, respectively. 
Tape Stripping Causes an Elevation ofp21""AFtlcn>t mRNA 
and Protein Expression in Human Skin There was a dramatic 
increase in both the mRNA and protein leve ls at 4 h after stripping, 
and these remained elevated at 24 h . Increased p21 WAFI / CIPI 
expression occurred equally in the basal and suprabasal epideml.is 
(Fig 3). 
DISCUSSION 
• Human Skin Mter Exposure to Irritants Both dithranol and 
Using a combination of immunohistochemistry and ;,, sit11 hybrid-
ization, we show increased expression of p21 WAFt / CtPI in psoriatic 
plaque skin in comparison with both normal and w1involved skin 
and demonstrate induction ofp21 WAFt /CIPI expression in skin after 
topical application of irritants and after seUotape stripping. The 
finding throughout the present experiments that p21 ""AFt / CtPt 
protein and mR.NA show almost identical patterns of expression 
provides strong evidence for the specificity of the antibody in 
human skin and also indicates that the major control of gene 
expression for p21 WAFt / CJPt is pretranslationaL Evidence from 
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Figure 3. Increased expression of p21 WAPliCJPt mRNA and protein at 4 h after sellotape stripping as compared with normal skin . Ju situ 
hybridization and immunohistochemistry were carried out as described in Materials and i\lletltods. a) p21 wAt' t/CtPt mRNA in tape-stripped skin: b) 
p21 WAP t/Cll ' t protein in tape-stripped skin; c) p21 WAF t/Ctl't mR.NA in normal skin; cf) p21 wArliCII't protein in normal skin. AU sections arc from the same 
volunteer. The dennocpidcm1aljunction is marked (dotted liues). Note that the increased expression ofp2lWAFI /Ctl'o mRNA and protein after tape stripping 
is in both the basal and supra basal layers. Bars , 10 J.Lm. 
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experiments on cell lines has suggested that tlus pretranslational 
control is by transcriptional regulation (19,27] . 
It is of interest that p 21 WAFl /CIPI expression in lesional psoriatic 
epiderm is was within the supra basal layer, as the majority of these 
cells are committed to terminal differentiation . Although earlier 
work indicated that p21 WAFJ/CIP'I is involved in mediating p53-
induced growth arrest and/or apoptosis (19] , recent work in a 
va riety of cell lin es has suggested that p21 WAFI/C IPl may also be 
in volved in regulating differentiation independent of p53 [27,28]. 
For example, p21 WAF I/CIPI is induced in HL- 60 cells within 3 h of 
exposure to agents that induce differentiation, such as 12-0-
tetradecanoylphorbol-1 3-acetate, retinoi c acid, or vitamin D 
[27 ,28] . T hese experiments have shown that in HL-60 cells, 
p21WAFt!CIPl expressio n is coupled to the expression of early 
differentiation markers and is uncoupled from apoptosis. Most 
importan t, beca use HL-60 cells are null for p53, the results show 
that these alterations in p21 WAF l/CIPI are independent ofp53 . Our 
results in psoriasis are consistent with involvement ofp21WAFl/CIPl 
in the differentiation of keratinocytes. However, in contrast to the 
increased expression of p21WAFI/CIPI that we observed supraba-
sa Uy in involved psoriasis, that following seUotape stripping w as 
througho ut the epidermis. T his suggests that p21WAFl /CIPI has 
other functions withiJ1 the epide rmis in addition to any putati ve role 
in terminal differentiation. 
Recent work has shown tl1 at p21 WAF t/CIP'I up-regulation can 
occur 11ia a p53-dependent or -inde pendent m echanism [26). 
Because of the i11 11 i11o n ature of the current experiment (it is not 
possible at present to examine p53-null psoriatic cells), it is not 
cer tain wh ether the p21 WAFl/CIPI elevation in psoriasis is p53 
dependent or p53 independent. However, two aspects of our 
resul ts provide grounds for suggesting that p21 WAFl /CIPl induction 
in psoriasis m ay be independent of p53. First, there was only a 
marginal elevation of p53 protein expression (without any differ-
ence in mRNA expression) , and , although prev io us studies have 
produced conflictin g results [ 44-4 7], the most convin cing study, 
by Moles et a/ [45], failed to show any significan t increase in p53 
imm unostaining in psoriasis. Second, the patte rns of staitung that 
we detected within the epidermis for p53 and p21WAFl /CIPI 
expression were different: p21 WAFI/Cil' l expression in psoriasis was 
supra basal, w hereas p53 staining was lu ghest in the lower epide rmal 
layers. 
T he increase in p21WA FI/CIPI expression is not specific for 
psoriatic epidermis; up-regul ation of p21 WAF I/C IPt also occurred in 
human ski n after the application of dithranol and SDS . Both of 
these induce proliferation, as reported previously [3 5-38] and as 
demonstrated by the increased Ki67 antigen expression that we 
obset·ved in th e irritant-treated skin. p21 WAF I/C WI induction was 
also evident after sellotape stripping, a classic stimulu s of prolifer-
ation [39,40]. However, although up-regulation of p21 WAF I/CIPt 
was seen during the hyperproliferative phase that fo llows treatment 
with d itlu·a nol and SDS [35-3 8], i t was also detected u1 skin 4 h 
after tape stripping, a tim e that p recedes any increase in prolifera-
tion (39,40]. T here fore, up-regulation of p21 WAFi f.C lPI is not a 
simp le accompanim ent of the hyperproliferative state. Further 
work using gene tic mo dels will be required to investigate any 
possible ca usal role of p21 WAFl/CJPt in keratinocyte differentiation 
and to determine whether p 21WAF't/CJPI may be a target for 
therapy in psoriasis. 
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